1073608-13-5
1073608-13-5
Chemical Structure
3,4-Dehydro Cilostazol-d11
Synonym(s): OPC-13015-d11
- CAS. Nr.: 1073608-13-5
- Formula:C20H14D11N5O2
- Molecular Weight:378.51
IUPAC Name: 6-(4-(1-(cyclohexyl-d11)-1H-tetrazol-5-yl)butoxy)quinolin-2(1H)-one
InChIKey: GHALECSGOJQOHW-SAGHCWGKSA-N
SMILES: O=C(N1)C=CC2=C1C=CC(OCCCCC3=NN=NN3C4([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C4([2H])[2H])=C2
Biological Activity: 3,4-Dehydro Cilostazol-d11 is deuterated labeled 3,4-Dehydro Cilostazol (HY-135910). 3,4-Dehydro Cilostazol (OPC-13015) is an active metabolite of Cilostazol (CLZ; HY-17464). 3,4-Dehydro Cilostazol is used for pharmacokinetic study[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
3,4-Dehydro Cilostazol-d11 | 3,4-Dehydro Cilostazol-d11 is deuterated labeled 3,4-Dehydro Cilostazol (HY-135910). 3,4-Dehydro Cilostazol (OPC-13015) is an active metabolite of Cilostazol (CLZ; HY-17464). 3,4-Dehydro Cilostazol is used for pharmacokinetic study. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3,4-Dehydro Cilostazol (Standard) | ≥98% | 3,4-Dehydro Cilostazol (Standard) is the analytical standard of 3,4-Dehydro Cilostazol. This product is intended for research and analytical applications. 3,4-Dehydro Cilostazol (OPC-13015) is an active metabolite of Cilostazol (CLZ; HY-17464). 3,4-Dehydro Cilostazol is used for pharmacokinetic study. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3,4-Dehydro Cilostazol | 98.10% | 3,4-Dehydro Cilostazol (OPC-13015) is an active metabolite of Cilostazol (CLZ; HY-17464). 3,4-Dehydro Cilostazol is used for pharmacokinetic study. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
